nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—Dexamethasone—multiple sclerosis	0.0668	0.446	CbGbCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Methylprednisolone—multiple sclerosis	0.0639	0.178	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Betamethasone—multiple sclerosis	0.0615	0.172	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Dexamethasone—multiple sclerosis	0.0615	0.172	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Triamcinolone—multiple sclerosis	0.0594	0.166	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—multiple sclerosis	0.0575	0.161	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Prednisone—multiple sclerosis	0.0543	0.152	CiPCiCtD
Amcinonide—Dexamethasone—multiple sclerosis	0.053	0.208	CrCtD
Amcinonide—Betamethasone—multiple sclerosis	0.053	0.208	CrCtD
Amcinonide—Triamcinolone—multiple sclerosis	0.0517	0.203	CrCtD
Amcinonide—Prednisone—multiple sclerosis	0.0491	0.193	CrCtD
Amcinonide—Prednisolone—multiple sclerosis	0.0479	0.188	CrCtD
Amcinonide—NR3C1—Methylprednisolone—multiple sclerosis	0.0206	0.137	CbGbCtD
Amcinonide—NR3C1—Triamcinolone—multiple sclerosis	0.0156	0.104	CbGbCtD
Amcinonide—NR3C1—Betamethasone—multiple sclerosis	0.0134	0.0894	CbGbCtD
Amcinonide—NR3C1—Prednisolone—multiple sclerosis	0.0132	0.0882	CbGbCtD
Amcinonide—NR3C1—Prednisone—multiple sclerosis	0.0125	0.0833	CbGbCtD
Amcinonide—NR3C1—Dexamethasone—multiple sclerosis	0.00779	0.052	CbGbCtD
Amcinonide—Ciclesonide—Methylprednisolone—multiple sclerosis	0.00182	0.00963	CrCrCtD
Amcinonide—Fluticasone furoate—Dexamethasone—multiple sclerosis	0.00172	0.00911	CrCrCtD
Amcinonide—Fluticasone furoate—Betamethasone—multiple sclerosis	0.00172	0.00911	CrCrCtD
Amcinonide—Fluticasone furoate—Triamcinolone—multiple sclerosis	0.00168	0.0089	CrCrCtD
Amcinonide—Ciclesonide—Prednisone—multiple sclerosis	0.00166	0.00879	CrCrCtD
Amcinonide—Flurandrenolide—Methylprednisolone—multiple sclerosis	0.00163	0.00861	CrCrCtD
Amcinonide—Ciclesonide—Prednisolone—multiple sclerosis	0.00162	0.00858	CrCrCtD
Amcinonide—Flurandrenolide—Dexamethasone—multiple sclerosis	0.0016	0.00847	CrCrCtD
Amcinonide—Flurandrenolide—Betamethasone—multiple sclerosis	0.0016	0.00847	CrCrCtD
Amcinonide—Flumethasone Pivalate—Methylprednisolone—multiple sclerosis	0.00157	0.00832	CrCrCtD
Amcinonide—Flumethasone Pivalate—Betamethasone—multiple sclerosis	0.00155	0.00819	CrCrCtD
Amcinonide—Flumethasone Pivalate—Dexamethasone—multiple sclerosis	0.00155	0.00819	CrCrCtD
Amcinonide—Halobetasol Propionate—Methylprednisolone—multiple sclerosis	0.00152	0.00805	CrCrCtD
Amcinonide—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00152	0.00805	CrCrCtD
Amcinonide—Difluprednate—Methylprednisolone—multiple sclerosis	0.00152	0.00805	CrCrCtD
Amcinonide—Flumethasone Pivalate—Triamcinolone—multiple sclerosis	0.00151	0.008	CrCrCtD
Amcinonide—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.0015	0.00793	CrCrCtD
Amcinonide—Difluprednate—Dexamethasone—multiple sclerosis	0.0015	0.00793	CrCrCtD
Amcinonide—Halobetasol Propionate—Dexamethasone—multiple sclerosis	0.0015	0.00793	CrCrCtD
Amcinonide—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.0015	0.00793	CrCrCtD
Amcinonide—Halobetasol Propionate—Betamethasone—multiple sclerosis	0.0015	0.00793	CrCrCtD
Amcinonide—Difluprednate—Betamethasone—multiple sclerosis	0.0015	0.00793	CrCrCtD
Amcinonide—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.00147	0.0078	CrCrCtD
Amcinonide—Difluprednate—Triamcinolone—multiple sclerosis	0.00146	0.00774	CrCrCtD
Amcinonide—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00146	0.00774	CrCrCtD
Amcinonide—Halobetasol Propionate—Triamcinolone—multiple sclerosis	0.00146	0.00774	CrCrCtD
Amcinonide—Flurandrenolide—Prednisolone—multiple sclerosis	0.00145	0.00767	CrCrCtD
Amcinonide—Prednicarbate—Methylprednisolone—multiple sclerosis	0.00143	0.00757	CrCrCtD
Amcinonide—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00143	0.00757	CrCrCtD
Amcinonide—Prednicarbate—Dexamethasone—multiple sclerosis	0.00141	0.00745	CrCrCtD
Amcinonide—Beclomethasone—Dexamethasone—multiple sclerosis	0.00141	0.00745	CrCrCtD
Amcinonide—Fluocinonide—Dexamethasone—multiple sclerosis	0.00141	0.00745	CrCrCtD
Amcinonide—Beclomethasone—Betamethasone—multiple sclerosis	0.00141	0.00745	CrCrCtD
Amcinonide—Fluocinonide—Betamethasone—multiple sclerosis	0.00141	0.00745	CrCrCtD
Amcinonide—Prednicarbate—Betamethasone—multiple sclerosis	0.00141	0.00745	CrCrCtD
Amcinonide—Prednicarbate—Triamcinolone—multiple sclerosis	0.00138	0.00728	CrCrCtD
Amcinonide—Beclomethasone—Triamcinolone—multiple sclerosis	0.00138	0.00728	CrCrCtD
Amcinonide—Fluocinonide—Triamcinolone—multiple sclerosis	0.00138	0.00728	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.00135	0.00715	CrCrCtD
Amcinonide—Cortisone acetate—Prednisone—multiple sclerosis	0.00135	0.00712	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.00133	0.00704	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.00133	0.00704	CrCrCtD
Amcinonide—Budesonide—Methylprednisolone—multiple sclerosis	0.00132	0.00696	CrCrCtD
Amcinonide—Cortisone acetate—Prednisolone—multiple sclerosis	0.00131	0.00695	CrCrCtD
Amcinonide—Prednicarbate—Prednisone—multiple sclerosis	0.00131	0.00691	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.0013	0.00688	CrCrCtD
Amcinonide—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00129	0.00685	CrCrCtD
Amcinonide—Budesonide—Dexamethasone—multiple sclerosis	0.00129	0.00685	CrCrCtD
Amcinonide—Budesonide—Betamethasone—multiple sclerosis	0.00129	0.00685	CrCrCtD
Amcinonide—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00129	0.00685	CrCrCtD
Amcinonide—Diflorasone—Methylprednisolone—multiple sclerosis	0.00128	0.00678	CrCrCtD
Amcinonide—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00128	0.00678	CrCrCtD
Amcinonide—Flunisolide—Methylprednisolone—multiple sclerosis	0.00128	0.00678	CrCrCtD
Amcinonide—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.00128	0.00678	CrCrCtD
Amcinonide—Desonide—Methylprednisolone—multiple sclerosis	0.00128	0.00678	CrCrCtD
Amcinonide—Prednisone—Methylprednisolone—multiple sclerosis	0.00128	0.00678	CrCrCtD
Amcinonide—Prednicarbate—Prednisolone—multiple sclerosis	0.00127	0.00675	CrCrCtD
Amcinonide—Beclomethasone—Prednisolone—multiple sclerosis	0.00127	0.00675	CrCrCtD
Amcinonide—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.00126	0.00669	CrCrCtD
Amcinonide—Budesonide—Triamcinolone—multiple sclerosis	0.00126	0.00669	CrCrCtD
Amcinonide—Clobetasol propionate—Betamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Desonide—Betamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Desonide—Dexamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Prednisone—Dexamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Prednisone—Betamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Diflorasone—Betamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Diflorasone—Dexamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Fludrocortisone—Dexamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Flunisolide—Betamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Flunisolide—Dexamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Fludrocortisone—Betamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.00126	0.00667	CrCrCtD
Amcinonide—Fludrocortisone—Triamcinolone—multiple sclerosis	0.00123	0.00652	CrCrCtD
Amcinonide—Desonide—Triamcinolone—multiple sclerosis	0.00123	0.00652	CrCrCtD
Amcinonide—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.00123	0.00652	CrCrCtD
Amcinonide—Prednisone—Triamcinolone—multiple sclerosis	0.00123	0.00652	CrCrCtD
Amcinonide—Flunisolide—Triamcinolone—multiple sclerosis	0.00123	0.00652	CrCrCtD
Amcinonide—Diflorasone—Triamcinolone—multiple sclerosis	0.00123	0.00652	CrCrCtD
Amcinonide—Desoximetasone—Methylprednisolone—multiple sclerosis	0.00122	0.00645	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.0012	0.00637	CrCrCtD
Amcinonide—Budesonide—Prednisone—multiple sclerosis	0.0012	0.00635	CrCrCtD
Amcinonide—Desoximetasone—Betamethasone—multiple sclerosis	0.0012	0.00635	CrCrCtD
Amcinonide—Desoximetasone—Dexamethasone—multiple sclerosis	0.0012	0.00635	CrCrCtD
Amcinonide—Mometasone—Methylprednisolone—multiple sclerosis	0.00119	0.0063	CrCrCtD
Amcinonide—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.00119	0.0063	CrCrCtD
Amcinonide—Loteprednol—Methylprednisolone—multiple sclerosis	0.00119	0.0063	CrCrCtD
Amcinonide—Fluorometholone—Methylprednisolone—multiple sclerosis	0.00119	0.0063	CrCrCtD
Amcinonide—Triamcinolone—Methylprednisolone—multiple sclerosis	0.00119	0.0063	CrCrCtD
Amcinonide—Desoximetasone—Triamcinolone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Fluoxymesterone—Prednisolone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Budesonide—Prednisolone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Mometasone—Betamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Triamcinolone—Betamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Mometasone—Dexamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Loteprednol—Betamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Fluorometholone—Dexamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Fluorometholone—Betamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Loteprednol—Dexamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Triamcinolone—Dexamethasone—multiple sclerosis	0.00117	0.0062	CrCrCtD
Amcinonide—Flunisolide—Prednisone—multiple sclerosis	0.00117	0.00619	CrCrCtD
Amcinonide—Clobetasol propionate—Prednisone—multiple sclerosis	0.00117	0.00619	CrCrCtD
Amcinonide—Fludrocortisone—Prednisone—multiple sclerosis	0.00117	0.00619	CrCrCtD
Amcinonide—Desonide—Prednisone—multiple sclerosis	0.00117	0.00619	CrCrCtD
Amcinonide—Diflorasone—Prednisone—multiple sclerosis	0.00117	0.00619	CrCrCtD
Amcinonide—Rimexolone—Methylprednisolone—multiple sclerosis	0.00116	0.00615	CrCrCtD
Amcinonide—Dexamethasone—Methylprednisolone—multiple sclerosis	0.00116	0.00615	CrCrCtD
Amcinonide—Betamethasone—Methylprednisolone—multiple sclerosis	0.00116	0.00615	CrCrCtD
Amcinonide—Rimexolone—Betamethasone—multiple sclerosis	0.00114	0.00606	CrCrCtD
Amcinonide—Rimexolone—Dexamethasone—multiple sclerosis	0.00114	0.00606	CrCrCtD
Amcinonide—Dexamethasone—Betamethasone—multiple sclerosis	0.00114	0.00606	CrCrCtD
Amcinonide—Betamethasone—Dexamethasone—multiple sclerosis	0.00114	0.00606	CrCrCtD
Amcinonide—Mometasone—Triamcinolone—multiple sclerosis	0.00114	0.00606	CrCrCtD
Amcinonide—Fluorometholone—Triamcinolone—multiple sclerosis	0.00114	0.00606	CrCrCtD
Amcinonide—Loteprednol—Triamcinolone—multiple sclerosis	0.00114	0.00606	CrCrCtD
Amcinonide—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.00114	0.00606	CrCrCtD
Amcinonide—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00114	0.00604	CrCrCtD
Amcinonide—Diflorasone—Prednisolone—multiple sclerosis	0.00114	0.00604	CrCrCtD
Amcinonide—Desonide—Prednisolone—multiple sclerosis	0.00114	0.00604	CrCrCtD
Amcinonide—Flunisolide—Prednisolone—multiple sclerosis	0.00114	0.00604	CrCrCtD
Amcinonide—Fludrocortisone—Prednisolone—multiple sclerosis	0.00114	0.00604	CrCrCtD
Amcinonide—Prednisone—Prednisolone—multiple sclerosis	0.00114	0.00604	CrCrCtD
Amcinonide—Betamethasone—Triamcinolone—multiple sclerosis	0.00112	0.00592	CrCrCtD
Amcinonide—Rimexolone—Triamcinolone—multiple sclerosis	0.00112	0.00592	CrCrCtD
Amcinonide—Dexamethasone—Triamcinolone—multiple sclerosis	0.00112	0.00592	CrCrCtD
Amcinonide—Desoximetasone—Prednisone—multiple sclerosis	0.00111	0.00589	CrCrCtD
Amcinonide—ANXA1—nerve—multiple sclerosis	0.00111	0.267	CbGeAlD
Amcinonide—Prednisolone—Methylprednisolone—multiple sclerosis	0.00109	0.00576	CrCrCtD
Amcinonide—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.00109	0.00575	CrCrCtD
Amcinonide—Triamcinolone—Prednisone—multiple sclerosis	0.00109	0.00575	CrCrCtD
Amcinonide—Mometasone—Prednisone—multiple sclerosis	0.00109	0.00575	CrCrCtD
Amcinonide—Fluorometholone—Prednisone—multiple sclerosis	0.00109	0.00575	CrCrCtD
Amcinonide—Loteprednol—Prednisone—multiple sclerosis	0.00109	0.00575	CrCrCtD
Amcinonide—Desoximetasone—Prednisolone—multiple sclerosis	0.00109	0.00574	CrCrCtD
Amcinonide—Prednisolone—Betamethasone—multiple sclerosis	0.00107	0.00567	CrCrCtD
Amcinonide—Prednisolone—Dexamethasone—multiple sclerosis	0.00107	0.00567	CrCrCtD
Amcinonide—Rimexolone—Prednisone—multiple sclerosis	0.00106	0.00561	CrCrCtD
Amcinonide—Betamethasone—Prednisone—multiple sclerosis	0.00106	0.00561	CrCrCtD
Amcinonide—Dexamethasone—Prednisone—multiple sclerosis	0.00106	0.00561	CrCrCtD
Amcinonide—Triamcinolone—Prednisolone—multiple sclerosis	0.00106	0.00561	CrCrCtD
Amcinonide—Loteprednol—Prednisolone—multiple sclerosis	0.00106	0.00561	CrCrCtD
Amcinonide—Fluorometholone—Prednisolone—multiple sclerosis	0.00106	0.00561	CrCrCtD
Amcinonide—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.00106	0.00561	CrCrCtD
Amcinonide—Mometasone—Prednisolone—multiple sclerosis	0.00106	0.00561	CrCrCtD
Amcinonide—Prednisolone—Triamcinolone—multiple sclerosis	0.00105	0.00554	CrCrCtD
Amcinonide—Betamethasone—Prednisolone—multiple sclerosis	0.00104	0.00548	CrCrCtD
Amcinonide—Rimexolone—Prednisolone—multiple sclerosis	0.00104	0.00548	CrCrCtD
Amcinonide—Dexamethasone—Prednisolone—multiple sclerosis	0.00104	0.00548	CrCrCtD
Amcinonide—Prednisolone—Prednisone—multiple sclerosis	0.000994	0.00526	CrCrCtD
Amcinonide—Secondary infection—Azathioprine—multiple sclerosis	0.000741	0.0235	CcSEcCtD
Amcinonide—Secondary adrenocortical insufficiency—Prednisone—multiple sclerosis	0.000605	0.0192	CcSEcCtD
Amcinonide—Dermatitis perioral—Triamcinolone—multiple sclerosis	0.000585	0.0186	CcSEcCtD
Amcinonide—Dermatitis perioral—Methylprednisolone—multiple sclerosis	0.000584	0.0185	CcSEcCtD
Amcinonide—Telangiectasia—Methylprednisolone—multiple sclerosis	0.000562	0.0178	CcSEcCtD
Amcinonide—Cataract subcapsular—Prednisolone—multiple sclerosis	0.000553	0.0175	CcSEcCtD
Amcinonide—Dermatitis perioral—Betamethasone—multiple sclerosis	0.000531	0.0168	CcSEcCtD
Amcinonide—Dermatitis perioral—Dexamethasone—multiple sclerosis	0.000531	0.0168	CcSEcCtD
Amcinonide—Acneiform eruption—Triamcinolone—multiple sclerosis	0.000526	0.0167	CcSEcCtD
Amcinonide—Acneiform eruption—Methylprednisolone—multiple sclerosis	0.000524	0.0166	CcSEcCtD
Amcinonide—Telangiectasia—Betamethasone—multiple sclerosis	0.000511	0.0162	CcSEcCtD
Amcinonide—Telangiectasia—Dexamethasone—multiple sclerosis	0.000511	0.0162	CcSEcCtD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.000509	0.0407	CbGpPWpGaD
Amcinonide—Cataract subcapsular—Triamcinolone—multiple sclerosis	0.000509	0.0161	CcSEcCtD
Amcinonide—Cataract subcapsular—Methylprednisolone—multiple sclerosis	0.000508	0.0161	CcSEcCtD
Amcinonide—Acneiform eruption—Dexamethasone—multiple sclerosis	0.000477	0.0151	CcSEcCtD
Amcinonide—Acneiform eruption—Betamethasone—multiple sclerosis	0.000477	0.0151	CcSEcCtD
Amcinonide—Cataract subcapsular—Dexamethasone—multiple sclerosis	0.000462	0.0146	CcSEcCtD
Amcinonide—Cataract subcapsular—Betamethasone—multiple sclerosis	0.000462	0.0146	CcSEcCtD
Amcinonide—Skin striae—Prednisolone—multiple sclerosis	0.000454	0.0144	CcSEcCtD
Amcinonide—Miliaria—Triamcinolone—multiple sclerosis	0.000452	0.0143	CcSEcCtD
Amcinonide—Secondary infection—Triamcinolone—multiple sclerosis	0.000452	0.0143	CcSEcCtD
Amcinonide—Secondary infection—Methylprednisolone—multiple sclerosis	0.000451	0.0143	CcSEcCtD
Amcinonide—Miliaria—Methylprednisolone—multiple sclerosis	0.000451	0.0143	CcSEcCtD
Amcinonide—Telangiectasia—Prednisone—multiple sclerosis	0.000445	0.0141	CcSEcCtD
Amcinonide—Atrophy—Prednisolone—multiple sclerosis	0.000443	0.0141	CcSEcCtD
Amcinonide—Skin atrophy—Triamcinolone—multiple sclerosis	0.00044	0.0139	CcSEcCtD
Amcinonide—Skin atrophy—Methylprednisolone—multiple sclerosis	0.000439	0.0139	CcSEcCtD
Amcinonide—Skin striae—Triamcinolone—multiple sclerosis	0.000418	0.0132	CcSEcCtD
Amcinonide—Skin striae—Methylprednisolone—multiple sclerosis	0.000417	0.0132	CcSEcCtD
Amcinonide—Acneiform eruption—Prednisone—multiple sclerosis	0.000415	0.0132	CcSEcCtD
Amcinonide—Secondary infection—Dexamethasone—multiple sclerosis	0.00041	0.013	CcSEcCtD
Amcinonide—Miliaria—Betamethasone—multiple sclerosis	0.00041	0.013	CcSEcCtD
Amcinonide—Secondary infection—Betamethasone—multiple sclerosis	0.00041	0.013	CcSEcCtD
Amcinonide—Miliaria—Dexamethasone—multiple sclerosis	0.00041	0.013	CcSEcCtD
Amcinonide—Atrophy—Triamcinolone—multiple sclerosis	0.000407	0.0129	CcSEcCtD
Amcinonide—Atrophy—Methylprednisolone—multiple sclerosis	0.000406	0.0129	CcSEcCtD
Amcinonide—Cataract subcapsular—Prednisone—multiple sclerosis	0.000402	0.0128	CcSEcCtD
Amcinonide—Skin atrophy—Dexamethasone—multiple sclerosis	0.000399	0.0127	CcSEcCtD
Amcinonide—Skin atrophy—Betamethasone—multiple sclerosis	0.000399	0.0127	CcSEcCtD
Amcinonide—Dermatitis acneiform—Triamcinolone—multiple sclerosis	0.000389	0.0123	CcSEcCtD
Amcinonide—Dermatitis acneiform—Methylprednisolone—multiple sclerosis	0.000388	0.0123	CcSEcCtD
Amcinonide—NR3C1—nerve—multiple sclerosis	0.000385	0.0929	CbGeAlD
Amcinonide—Allergic contact dermatitis—Triamcinolone—multiple sclerosis	0.00038	0.0121	CcSEcCtD
Amcinonide—Skin striae—Dexamethasone—multiple sclerosis	0.000379	0.012	CcSEcCtD
Amcinonide—Skin striae—Betamethasone—multiple sclerosis	0.000379	0.012	CcSEcCtD
Amcinonide—Telangiectasia—Methotrexate—multiple sclerosis	0.000372	0.0118	CcSEcCtD
Amcinonide—Atrophy—Betamethasone—multiple sclerosis	0.00037	0.0117	CcSEcCtD
Amcinonide—Atrophy—Dexamethasone—multiple sclerosis	0.00037	0.0117	CcSEcCtD
Amcinonide—Dermatitis acneiform—Betamethasone—multiple sclerosis	0.000353	0.0112	CcSEcCtD
Amcinonide—Dermatitis acneiform—Dexamethasone—multiple sclerosis	0.000353	0.0112	CcSEcCtD
Amcinonide—Hypertrichosis—Triamcinolone—multiple sclerosis	0.000349	0.0111	CcSEcCtD
Amcinonide—Hypertrichosis—Methylprednisolone—multiple sclerosis	0.000348	0.0111	CcSEcCtD
Amcinonide—Skin atrophy—Prednisone—multiple sclerosis	0.000347	0.011	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Betamethasone—multiple sclerosis	0.000345	0.0109	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Dexamethasone—multiple sclerosis	0.000345	0.0109	CcSEcCtD
Amcinonide—Leukoderma—Prednisolone—multiple sclerosis	0.00034	0.0108	CcSEcCtD
Amcinonide—ANXA1—medulla oblongata—multiple sclerosis	0.000332	0.08	CbGeAlD
Amcinonide—Skin striae—Prednisone—multiple sclerosis	0.00033	0.0105	CcSEcCtD
Amcinonide—Atrophy—Prednisone—multiple sclerosis	0.000322	0.0102	CcSEcCtD
Amcinonide—Hypertrichosis—Dexamethasone—multiple sclerosis	0.000317	0.0101	CcSEcCtD
Amcinonide—Hypertrichosis—Betamethasone—multiple sclerosis	0.000317	0.0101	CcSEcCtD
Amcinonide—Leukoderma—Triamcinolone—multiple sclerosis	0.000312	0.00991	CcSEcCtD
Amcinonide—Leukoderma—Methylprednisolone—multiple sclerosis	0.000312	0.00988	CcSEcCtD
Amcinonide—Dermatitis acneiform—Prednisone—multiple sclerosis	0.000307	0.00974	CcSEcCtD
Amcinonide—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	0.000306	0.0245	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MBP—multiple sclerosis	0.000304	0.0244	CbGpPWpGaD
Amcinonide—ANXA1—midbrain—multiple sclerosis	0.000303	0.0731	CbGeAlD
Amcinonide—ANXA1—spinal cord—multiple sclerosis	0.000296	0.0714	CbGeAlD
Amcinonide—Leukoderma—Betamethasone—multiple sclerosis	0.000283	0.00899	CcSEcCtD
Amcinonide—Leukoderma—Dexamethasone—multiple sclerosis	0.000283	0.00899	CcSEcCtD
Amcinonide—Hypertrichosis—Prednisone—multiple sclerosis	0.000276	0.00875	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.00025	0.02	CbGpPWpGaD
Amcinonide—ANXA1—nervous system—multiple sclerosis	0.000249	0.0601	CbGeAlD
Amcinonide—Leukoderma—Prednisone—multiple sclerosis	0.000247	0.00783	CcSEcCtD
Amcinonide—ANXA1—central nervous system—multiple sclerosis	0.00024	0.0579	CbGeAlD
Amcinonide—ANXA1—cerebellum—multiple sclerosis	0.000235	0.0566	CbGeAlD
Amcinonide—ANXA1—Spinal Cord Injury—AQP4—multiple sclerosis	0.000231	0.0185	CbGpPWpGaD
Amcinonide—Folliculitis—Triamcinolone—multiple sclerosis	0.000211	0.0067	CcSEcCtD
Amcinonide—Folliculitis—Methylprednisolone—multiple sclerosis	0.000211	0.00669	CcSEcCtD
Amcinonide—Leukoderma—Methotrexate—multiple sclerosis	0.000206	0.00654	CcSEcCtD
Amcinonide—ANXA1—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.000194	0.0155	CbGpPWpGaD
Amcinonide—Folliculitis—Betamethasone—multiple sclerosis	0.000192	0.00608	CcSEcCtD
Amcinonide—Folliculitis—Dexamethasone—multiple sclerosis	0.000192	0.00608	CcSEcCtD
Amcinonide—ANXA1—brain—multiple sclerosis	0.000191	0.046	CbGeAlD
Amcinonide—ANXA1—G alpha (q) signalling events—GPR65—multiple sclerosis	0.000188	0.015	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000185	0.0148	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000184	0.0148	CbGpPWpGaD
Amcinonide—Stinging—Prednisolone—multiple sclerosis	0.000178	0.00565	CcSEcCtD
Amcinonide—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	0.000176	0.0141	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	0.000176	0.0141	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.000169	0.0136	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.000169	0.0136	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.000168	0.0134	CbGpPWpGaD
Amcinonide—Infection—Fingolimod—multiple sclerosis	0.000167	0.00531	CcSEcCtD
Amcinonide—NR3C1—brainstem—multiple sclerosis	0.000165	0.0399	CbGeAlD
Amcinonide—ANXA1—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000165	0.0132	CbGpPWpGaD
Amcinonide—Stinging—Triamcinolone—multiple sclerosis	0.000164	0.0052	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—CCR2—multiple sclerosis	0.00016	0.0128	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000154	0.0123	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	0.000151	0.0121	CbGpPWpGaD
Amcinonide—Stinging—Betamethasone—multiple sclerosis	0.000149	0.00472	CcSEcCtD
Amcinonide—Stinging—Dexamethasone—multiple sclerosis	0.000149	0.00472	CcSEcCtD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000143	0.0114	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000143	0.0114	CbGpPWpGaD
Amcinonide—Folliculitis—Methotrexate—multiple sclerosis	0.000139	0.00442	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000133	0.0106	CbGpPWpGaD
Amcinonide—Dermatitis contact—Triamcinolone—multiple sclerosis	0.000131	0.00416	CcSEcCtD
Amcinonide—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	0.000131	0.0105	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000124	0.00995	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.000121	0.00967	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—BDNF—multiple sclerosis	0.000119	0.00955	CbGpPWpGaD
Amcinonide—Pruritus—Fingolimod—multiple sclerosis	0.000119	0.00378	CcSEcCtD
Amcinonide—Dermatitis contact—Dexamethasone—multiple sclerosis	0.000119	0.00378	CcSEcCtD
Amcinonide—Dermatitis contact—Betamethasone—multiple sclerosis	0.000119	0.00378	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—S1PR1—multiple sclerosis	0.000117	0.0094	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	0.000116	0.00928	CbGpPWpGaD
Amcinonide—NR3C1—medulla oblongata—multiple sclerosis	0.000115	0.0278	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000114	0.0091	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000114	0.0091	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.000112	0.00899	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL4—multiple sclerosis	0.000111	0.00887	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.000109	0.00874	CbGpPWpGaD
Amcinonide—NR3C1—midbrain—multiple sclerosis	0.000105	0.0254	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000104	0.0083	CbGpPWpGaD
Amcinonide—NR3C1—spinal cord—multiple sclerosis	0.000103	0.0248	CbGeAlD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000101	0.00809	CbGpPWpGaD
Amcinonide—Infection—Cladribine—multiple sclerosis	9.49e-05	0.00301	CcSEcCtD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCR3—multiple sclerosis	9.47e-05	0.00758	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GPR65—multiple sclerosis	9.46e-05	0.00758	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CCR2—multiple sclerosis	9.21e-05	0.00738	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TLR4—multiple sclerosis	9.18e-05	0.00735	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	9.16e-05	0.00734	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	9.07e-05	0.00727	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—ICAM1—multiple sclerosis	8.8e-05	0.00705	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	8.69e-05	0.00696	CbGpPWpGaD
Amcinonide—NR3C1—nervous system—multiple sclerosis	8.66e-05	0.0209	CbGeAlD
Amcinonide—ANXA1—GPCR ligand binding—CXCL13—multiple sclerosis	8.65e-05	0.00693	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCR1—multiple sclerosis	8.65e-05	0.00693	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CNR1—multiple sclerosis	8.5e-05	0.00681	CbGpPWpGaD
Amcinonide—NR3C1—central nervous system—multiple sclerosis	8.34e-05	0.0201	CbGeAlD
Amcinonide—Pain—Cladribine—multiple sclerosis	8.17e-05	0.00259	CcSEcCtD
Amcinonide—NR3C1—cerebellum—multiple sclerosis	8.15e-05	0.0197	CbGeAlD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	8.12e-05	0.0065	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	8.1e-05	0.00649	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCL2—multiple sclerosis	7.88e-05	0.00631	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCL5—multiple sclerosis	7.81e-05	0.00625	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	7.8e-05	0.00624	CbGpPWpGaD
Amcinonide—Infection—Azathioprine—multiple sclerosis	7.72e-05	0.00245	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	7.69e-05	0.00616	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL10—multiple sclerosis	7.65e-05	0.00613	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	7.53e-05	0.00603	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	7.32e-05	0.00587	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—PGR—multiple sclerosis	7.27e-05	0.286	CrCbGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	7.24e-05	0.0058	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCR5—multiple sclerosis	7.04e-05	0.00563	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.94e-05	0.00556	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	6.76e-05	0.00541	CbGpPWpGaD
Amcinonide—Pruritus—Cladribine—multiple sclerosis	6.76e-05	0.00214	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—IFNG—multiple sclerosis	6.7e-05	0.00536	CbGpPWpGaD
Amcinonide—Betamethasone—PGR—multiple sclerosis	6.66e-05	0.262	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—S1PR1—multiple sclerosis	6.63e-05	0.00531	CbGpPWpGaD
Amcinonide—NR3C1—brain—multiple sclerosis	6.62e-05	0.016	CbGeAlD
Amcinonide—ANXA1—G alpha (i) signalling events—CCL5—multiple sclerosis	6.59e-05	0.00528	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	6.3e-05	0.00504	CbGpPWpGaD
Amcinonide—Infection—Mitoxantrone—multiple sclerosis	6.24e-05	0.00198	CcSEcCtD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	6.2e-05	0.00497	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL3—multiple sclerosis	6.17e-05	0.00494	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	6.09e-05	0.00487	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—S1PR1—multiple sclerosis	6.02e-05	0.00482	CbGpPWpGaD
Amcinonide—Dermatitis—Cladribine—multiple sclerosis	6.02e-05	0.00191	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—IL1B—multiple sclerosis	5.97e-05	0.00478	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL2—multiple sclerosis	5.95e-05	0.00477	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—PTGER4—multiple sclerosis	5.94e-05	0.00475	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CCR5—multiple sclerosis	5.94e-05	0.00475	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	5.93e-05	0.00475	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	5.83e-05	0.00467	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCR3—multiple sclerosis	5.73e-05	0.00459	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—RGS1—multiple sclerosis	5.64e-05	0.00452	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MMP9—multiple sclerosis	5.63e-05	0.00451	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCR2—multiple sclerosis	5.58e-05	0.00447	CbGpPWpGaD
Amcinonide—Triamcinolone—BCHE—multiple sclerosis	5.57e-05	0.219	CrCbGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—POMC—multiple sclerosis	5.5e-05	0.0044	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	5.47e-05	0.00438	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	5.38e-05	0.00431	CbGpPWpGaD
Amcinonide—Pain—Mitoxantrone—multiple sclerosis	5.37e-05	0.0017	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—GPR65—multiple sclerosis	5.35e-05	0.00428	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	5.32e-05	0.00426	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	5.25e-05	0.00421	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	5.24e-05	0.0042	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CNR1—multiple sclerosis	5.15e-05	0.00412	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RGS1—multiple sclerosis	5.12e-05	0.0041	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	5.11e-05	0.00409	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	5e-05	0.004	CbGpPWpGaD
Amcinonide—Dermatitis—Azathioprine—multiple sclerosis	4.89e-05	0.00155	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—CCR1—multiple sclerosis	4.89e-05	0.00392	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL13—multiple sclerosis	4.89e-05	0.00392	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	4.86e-05	0.00389	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GPR65—multiple sclerosis	4.86e-05	0.00389	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	4.82e-05	0.00386	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	4.72e-05	0.00378	CbGpPWpGaD
Amcinonide—Infection—Triamcinolone—multiple sclerosis	4.71e-05	0.00149	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—LINGO1—multiple sclerosis	4.7e-05	0.00376	CbGpPWpGaD
Amcinonide—Infection—Methylprednisolone—multiple sclerosis	4.7e-05	0.00149	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	4.68e-05	0.00375	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MYC—multiple sclerosis	4.65e-05	0.00373	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TGFB1—multiple sclerosis	4.64e-05	0.00372	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—POMC—multiple sclerosis	4.64e-05	0.00372	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL10—multiple sclerosis	4.63e-05	0.00371	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK1—multiple sclerosis	4.55e-05	0.00365	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL13—multiple sclerosis	4.44e-05	0.00356	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR1—multiple sclerosis	4.44e-05	0.00356	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	4.43e-05	0.00354	CbGpPWpGaD
Amcinonide—Pain—Prednisolone—multiple sclerosis	4.4e-05	0.0014	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—multiple sclerosis	4.33e-05	0.00347	CbGpPWpGaD
Amcinonide—Infection—Betamethasone—multiple sclerosis	4.27e-05	0.00135	CcSEcCtD
Amcinonide—Infection—Dexamethasone—multiple sclerosis	4.27e-05	0.00135	CcSEcCtD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	4.24e-05	0.00339	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TAGAP—multiple sclerosis	4.07e-05	0.00326	CbGpPWpGaD
Amcinonide—Pain—Triamcinolone—multiple sclerosis	4.05e-05	0.00128	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—CCL5—multiple sclerosis	3.99e-05	0.00319	CbGpPWpGaD
Amcinonide—Dermatitis—Mitoxantrone—multiple sclerosis	3.96e-05	0.00125	CcSEcCtD
Amcinonide—Dexamethasone—PGR—multiple sclerosis	3.88e-05	0.152	CrCbGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	3.82e-05	0.00306	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	3.78e-05	0.00303	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	3.74e-05	0.00299	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	3.72e-05	0.00298	CbGpPWpGaD
Amcinonide—Infection—Prednisone—multiple sclerosis	3.72e-05	0.00118	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.69e-05	0.00295	CbGpPWpGaD
Amcinonide—Pain—Dexamethasone—multiple sclerosis	3.68e-05	0.00117	CcSEcCtD
Amcinonide—Pain—Betamethasone—multiple sclerosis	3.68e-05	0.00117	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	3.61e-05	0.00289	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCR5—multiple sclerosis	3.59e-05	0.00288	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—S1PR1—multiple sclerosis	3.56e-05	0.00285	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—multiple sclerosis	3.5e-05	0.0028	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GPC5—multiple sclerosis	3.46e-05	0.00277	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	3.4e-05	0.00273	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PTGER4—multiple sclerosis	3.35e-05	0.00269	CbGpPWpGaD
Amcinonide—Pruritus—Triamcinolone—multiple sclerosis	3.35e-05	0.00106	CcSEcCtD
Amcinonide—Pruritus—Methylprednisolone—multiple sclerosis	3.34e-05	0.00106	CcSEcCtD
Amcinonide—Dermatitis—Prednisolone—multiple sclerosis	3.24e-05	0.00103	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—CXCR3—multiple sclerosis	3.24e-05	0.00259	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	3.21e-05	0.00257	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.17e-05	0.00253	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL3—multiple sclerosis	3.16e-05	0.00253	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.16e-05	0.00253	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR2—multiple sclerosis	3.15e-05	0.00252	CbGpPWpGaD
Amcinonide—Infection—Methotrexate—multiple sclerosis	3.11e-05	0.000986	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.1e-05	0.00248	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PTGER4—multiple sclerosis	3.05e-05	0.00244	CbGpPWpGaD
Amcinonide—Pruritus—Betamethasone—multiple sclerosis	3.04e-05	0.000965	CcSEcCtD
Amcinonide—Pruritus—Dexamethasone—multiple sclerosis	3.04e-05	0.000965	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—RGS1—multiple sclerosis	3.03e-05	0.00242	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	3.02e-05	0.00241	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—FAS—multiple sclerosis	2.99e-05	0.00239	CbGpPWpGaD
Amcinonide—Dermatitis—Triamcinolone—multiple sclerosis	2.98e-05	0.000946	CcSEcCtD
Amcinonide—Dermatitis—Methylprednisolone—multiple sclerosis	2.98e-05	0.000944	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.95e-05	0.00236	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCR3—multiple sclerosis	2.94e-05	0.00236	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CNR1—multiple sclerosis	2.91e-05	0.00233	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	2.88e-05	0.00231	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GPR65—multiple sclerosis	2.87e-05	0.0023	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR2—multiple sclerosis	2.86e-05	0.00229	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	2.86e-05	0.00229	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ZNF746—multiple sclerosis	2.86e-05	0.00229	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	2.83e-05	0.00227	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.82e-05	0.00226	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—POMC—multiple sclerosis	2.81e-05	0.00225	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL2—multiple sclerosis	2.75e-05	0.0022	CbGpPWpGaD
Amcinonide—Dermatitis—Betamethasone—multiple sclerosis	2.71e-05	0.000859	CcSEcCtD
Amcinonide—Dermatitis—Dexamethasone—multiple sclerosis	2.71e-05	0.000859	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	2.7e-05	0.00216	CbGpPWpGaD
Amcinonide—Pain—Methotrexate—multiple sclerosis	2.68e-05	0.000849	CcSEcCtD
Amcinonide—Pruritus—Prednisone—multiple sclerosis	2.65e-05	0.00084	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—CNR1—multiple sclerosis	2.64e-05	0.00212	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR1—multiple sclerosis	2.62e-05	0.0021	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL13—multiple sclerosis	2.62e-05	0.0021	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.62e-05	0.0021	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PTBP1—multiple sclerosis	2.61e-05	0.00209	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	2.52e-05	0.00202	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL10—multiple sclerosis	2.38e-05	0.0019	CbGpPWpGaD
Amcinonide—Dermatitis—Prednisone—multiple sclerosis	2.36e-05	0.000748	CcSEcCtD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	2.28e-05	0.00183	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCL5—multiple sclerosis	2.25e-05	0.00181	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	2.23e-05	0.00179	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	2.23e-05	0.00178	CbGpPWpGaD
Amcinonide—Pruritus—Methotrexate—multiple sclerosis	2.21e-05	0.000702	CcSEcCtD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.16e-05	0.00173	CbGpPWpGaD
Amcinonide—Prednisone—ALB—multiple sclerosis	2.07e-05	0.0814	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL5—multiple sclerosis	2.05e-05	0.00164	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR5—multiple sclerosis	2.03e-05	0.00163	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2RA—multiple sclerosis	2e-05	0.0016	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.99e-05	0.00159	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—U2AF2—multiple sclerosis	1.98e-05	0.00158	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	1.98e-05	0.00158	CbGpPWpGaD
Amcinonide—Dermatitis—Methotrexate—multiple sclerosis	1.97e-05	0.000625	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	1.92e-05	0.00154	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL3—multiple sclerosis	1.87e-05	0.0015	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR5—multiple sclerosis	1.84e-05	0.00148	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2RA—multiple sclerosis	1.82e-05	0.00146	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTGER4—multiple sclerosis	1.8e-05	0.00144	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	1.79e-05	0.00143	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PGR—multiple sclerosis	1.77e-05	0.00142	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCR3—multiple sclerosis	1.74e-05	0.00139	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CD28—multiple sclerosis	1.72e-05	0.00138	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR2—multiple sclerosis	1.69e-05	0.00135	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	1.68e-05	0.00134	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—POMC—multiple sclerosis	1.59e-05	0.00127	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	1.56e-05	0.00125	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CNR1—multiple sclerosis	1.56e-05	0.00125	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.51e-05	0.00121	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	1.48e-05	0.00118	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—STAT3—multiple sclerosis	1.46e-05	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—POMC—multiple sclerosis	1.44e-05	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL2—multiple sclerosis	1.41e-05	0.00113	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL10—multiple sclerosis	1.4e-05	0.00113	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	1.36e-05	0.00109	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—TYK2—multiple sclerosis	1.28e-05	0.00103	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—multiple sclerosis	1.27e-05	0.00102	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	1.25e-05	0.001	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CD86—multiple sclerosis	1.23e-05	0.000984	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PABPC1—multiple sclerosis	1.21e-05	0.000971	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL5—multiple sclerosis	1.21e-05	0.000968	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2—multiple sclerosis	1.17e-05	0.00094	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SPP1—multiple sclerosis	1.12e-05	0.000897	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.1e-05	0.000877	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL5—multiple sclerosis	1.09e-05	0.000876	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR5—multiple sclerosis	1.09e-05	0.000872	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2RA—multiple sclerosis	1.07e-05	0.00086	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2—multiple sclerosis	1.07e-05	0.000853	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—multiple sclerosis	1.02e-05	0.000819	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—multiple sclerosis	9.91e-06	0.000794	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CD80—multiple sclerosis	8.96e-06	0.000718	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.84e-06	0.000708	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PGR—multiple sclerosis	8.61e-06	0.00069	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—POMC—multiple sclerosis	8.51e-06	0.000682	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL2—multiple sclerosis	8.33e-06	0.000667	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK1—multiple sclerosis	8.15e-06	0.000653	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TYK2—multiple sclerosis	7.57e-06	0.000606	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2—multiple sclerosis	6.29e-06	0.000504	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—multiple sclerosis	6.26e-06	0.000502	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—VDR—multiple sclerosis	6.02e-06	0.000482	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—multiple sclerosis	5.96e-06	0.000477	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—multiple sclerosis	5.3e-06	0.000424	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	4.97e-06	0.000398	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—multiple sclerosis	4.92e-06	0.000394	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—multiple sclerosis	4.91e-06	0.000393	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK1—multiple sclerosis	4.82e-06	0.000386	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—multiple sclerosis	3.7e-06	0.000296	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—multiple sclerosis	2.39e-06	0.000192	CbGpPWpGaD
